Cigna Corp. (CI) Tops Q3 EPS by 19c, Beats on Revenue; Offers FY25 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts CI Hot Sheet
Price: $305.41 +3.37%
Revenue Growth %: +4.2%
Financial Fact:
Mail order pharmacy cost of goods sold: 638M
Today's EPS Names:
COHR, ATS, SICP, More
Revenue Growth %: +4.2%
Financial Fact:
Mail order pharmacy cost of goods sold: 638M
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
Cigna Corp. (NYSE: CI) reported Q3 EPS of $7.83, $0.19 better than the analyst estimate of $7.64. Revenue for the quarter came in at $69.7 billion versus the consensus estimate of $67.61 billion.
GUIDANCE:
Cigna Corp. sees FY2025 EPS of $29.60, versus the consensus of $29.63.
For earnings history and earnings-related data on Cigna Corp. (CI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Veracyte (VCYT) Tops Q3 EPS by 10c ; Offers Guidance
- Steris (STE) Tops Q3 EPS by 26c ; Offers Guidance
- Red Violet (RDVT) Tops Q3 EPS by 6c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
